Byooviz 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection Images
Generic Name: ranibizumab
This medication has been identified as Byooviz 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection and is used for Macular Degeneration, Macular Edema Following Retinal Vein Occlusion, Myopic Choroidal Neovascularization, and Macular Edema. It belongs to the drug class anti-angiogenic ophthalmic agents and is not a controlled substance.
Images of medication
Byooviz
- Generic Name
- ranibizumab
- Strength
- 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection
- Availability
- Prescription only
- Drug Class
- Anti-angiogenic ophthalmic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Biogen
- National Drug Code (NDC)
- 64406-0019
See also:
More about Byooviz (ranibizumab ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.